N Verses Capital, LLC Artivion, Inc. Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Artivion, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 1,100 shares of AORT stock, worth $27,775. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,100Holding current value
$27,775% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
166Shares Held
35.4MCall Options Held
21KPut Options Held
6.8K-
Black Rock Inc. New York, NY6.64MShares$168 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.81MShares$71 Million0.08% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$70.5 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.77MShares$70 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.36MShares$59.6 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.02B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...